Cullinan Therapeutics, Inc. Liquidation Value
CGEM
Other
Cash & Equivalents
$88.33M
As of 2025-12-31
Current Price: N/A
Key Metrics
Cash Liquidation Value
Cash minus Total Obligations
Cash: $88.33M
Total Obligations: -$40.42M
$47.91M
Per share: $0.80
Period: 2025-12-31
Liquid Liquidation Value
Cash + AR minus Total Obligations
Cash: $88.33M
AR: $0
Total Obligations: -$40.42M
$47.91M
Per share: $0.80
Period: 2025-12-31
Operating Liquidation Value
Cash + AR + Inventory minus Total Obligations
Cash: $88.33M
AR: $0
Inventory: $0
Total Obligations: -$40.42M
$47.91M
Per share: $0.80
Period: 2025-12-31
Build your own liquidation scenario
Adjust asset discounts and liability assumptions to see how assumptions affect the numbers.
Liquidation Ladder
| Metric | Total | Per Share |
|---|---|---|
| Cash Liquidation Value | $47.91M | $0.80 |
| Liquid Liquidation Value | $47.91M | $0.80 |
| Operating Liquidation Value | $47.91M | $0.80 |
Key Components (as of 2025-12-31)
| Cash & Equivalents | $88.33M |
| Accounts Receivable | N/A |
| Inventory | N/A |
| Current Liabilities | $37.74M |
| Long-term Debt | N/A |
| Op. Lease Liability | $2.68M |
| Finance Lease | N/A |
| Shares Outstanding | 60.2M |
Explore all 136 XBRL tags and build your own scenario → Open Calculator
Historical
| Period | Cash | AR | Inventory | AP | Curr Liab | LT Debt | Op Lease | Fin Lease |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $88.33M | N/A | N/A | $841,000 | $37.74M | N/A | $2.68M | N/A |
| 2025-09-30 | $103.33M | N/A | N/A | $1.72M | $32.76M | N/A | $1.19M | N/A |
| 2025-06-30 | $72.82M | N/A | N/A | $2.46M | $28.06M | N/A | $1.52M | N/A |
| 2025-03-31 | $76.66M | N/A | N/A | $3.40M | $27.35M | N/A | $1.84M | N/A |
| 2024-12-31 | $83.00M | N/A | N/A | $1.68M | $30.65M | N/A | $2.15M | N/A |
| 2024-09-30 | $102.08M | N/A | N/A | $2.12M | $24.20M | N/A | $2.45M | N/A |
| 2024-06-30 | $115.02M | N/A | N/A | $1.55M | $23.48M | N/A | $2.73M | N/A |
| 2024-03-31 | $74.23M | N/A | N/A | $3.71M | $21.93M | N/A | $3.17M | N/A |
▼ Community Notes